Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for APQR Compilation for Regulatory Use – V 2.0

Posted on By

API Manufacturing: SOP for APQR Compilation for Regulatory Use – V 2.0

Standard Operating Procedure for APQR Compilation for Regulatory Use in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/179/2025
Supersedes SOP/API/179/2022
Page No. Page 1 of 14
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define the procedure for the compilation, review, and approval of the Annual Product Quality Review (APQR) for APIs manufactured, ensuring compliance with ICH Q7, WHO, EU GMP, and other regulatory agency expectations.

2. Scope

This SOP applies to all API products manufactured at the site for which annual review is required to evaluate consistency, quality trends, deviations, changes, stability results,

complaints, and validation status.

3. Responsibilities

  • QA Executive: Coordinates data collection, compiles and reviews the APQR draft.
  • Functional Departments (Production, QC, Warehouse, Regulatory Affairs): Provide required data and supporting documents.
  • QA Manager: Reviews compiled report and recommends for approval.
  • Site Head/Plant Manager: Provides final approval of APQR.
See also  API Manufacturing: SOP for System Suitability Testing in HPLC - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring the accuracy, completeness, and timely submission of APQRs to meet internal and regulatory requirements.

5. Procedure

5.1 APQR Calendar and Product List

  1. QA shall prepare and maintain an Annual APQR Calendar (Annexure-1) listing all products requiring review.
  2. The calendar must be approved by QA Head and shared with department heads.

5.2 Data Collection

  1. QA shall collect the following data for the review period (typically Jan–Dec):
    • Batch manufacturing and release data
    • Yield trends
    • Deviation and non-conformance reports
    • Change controls
    • Market complaints and recalls
    • OOS/OOT results
    • Stability study status
    • Analytical method changes
    • Validation/revalidation data
    • Environmental monitoring data
  2. Data to be submitted in soft copy and/or controlled formats by relevant departments using the Data Submission Template (Annexure-2).

5.3 Compilation of APQR

  1. QA shall compile data into the APQR Compilation Template (Annexure-3) including:
    • Product overview
    • Manufacturing summary and yields
    • Quality metrics and trends
    • Stability performance
    • Regulatory commitments and deviations
    • CAPAs implemented
    • Recommendations for improvement
  2. Graphical and tabular representations must be included where applicable.
See also  API Manufacturing: SOP for Review and Approval of Batch Manufacturing Records (BMR) - V 2.0

5.4 Review and Approval Process

  1. QA Manager shall review the draft APQR for:
    • Completeness
    • Consistency of data
    • Corrective actions suggested
  2. Final report shall be approved by QA Head and Site Head.
  3. All approval signatures must be dated, and the APQR must be version controlled.

5.5 Submission and Archival

  1. Approved APQRs shall be:
    • Shared with Regulatory Affairs and retained for inspection readiness
    • Archived in both hard copy and electronic format
  2. Retention period: Minimum 5 years or as per local regulations.

5.6 Trending and Improvements

  1. Based on APQR findings, QA shall initiate recommendations which may include:
    • Process optimization
    • SOP revision
    • Further training
    • Revalidation
  2. Action points to be documented and followed via CAPA system.

6. Abbreviations

  • APQR: Annual Product Quality Review
  • QA: Quality Assurance
  • OOS: Out of Specification
  • OOT: Out of Trend
  • CAPA: Corrective and Preventive Action

7. Documents

  1. APQR Calendar (Annexure-1)
  2. Data Submission Template (Annexure-2)
  3. APQR Compilation Template (Annexure-3)
  4. CAPA Tracking Sheet (Annexure-4)
See also  API Manufacturing: SOP for Intermediate Moisture Check using IR Balance - V 2.0

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211.180(e) – APQR
  • EU GMP Part I – Chapter 1 and 9

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: APQR Calendar

Product Name API Code Review Period Due Date Status
API-X AXP001 Jan–Dec 2024 31/03/2025 Pending

Annexure-2: Data Submission Template

Department Data Type Format Submitted On
QC OOS Report Summary Excel 01/03/2025

Annexure-3: APQR Compilation Template

Section Data Summary Remarks
Yield Trend Average: 98.5% Within control limits
Deviations 2 major, 3 minor Investigated and closed

Annexure-4: CAPA Tracking Sheet

CAPA No. Action Owner Due Date Status
CAPA/2025/04 Update granulation SOP Production 10/04/2025 Open

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New document QA Head
14/04/2025 2.0 Added CAPA tracking and annexures Process enhancement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Gel Manufacturing: SOP for Ensuring Uniform Mixing During Gel Production – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Setting Parameters for Vial Filling Machines – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version